Cripto is a membrane-bound co-receptor for Nodal, a member of the transforming growth factor-␤ superfamily. Mouse embryos lacking either Cripto or Nodal have the same lethal phenotype at embryonic day 7.5. Previous studies suggest that O-fucosylation of the epidermal growth factor-like (EGF) repeat in Cripto is essential for the facilitation of Nodal signaling. Substitution of Ala for the Thr to which O-fucose is attached led to functional inactivation of both human and mouse Cripto. However, embryos null for protein O-fucosyltransferase 1, the enzyme that adds O-fucose to EGF repeats, do not exhibit a Cripto null phenotype and die at about embryonic day 9. Nodal, a member of the TGF-␤ 4 superfamily, plays essential roles in the embryonic development of vertebrates, including mesoderm formation and the generation of left-right asymmetry (1). The major components of the Nodal-signaling pathway are the soluble ligand Nodal, activin membrane receptors (ActRIIB and ALK4) to which Nodal binds, Smad2 and Smad4 signal-transducing molecules, and the transcription factor Fast1 (FoxH1). In addition, Cripto, a membrane glycoprotein with a glycosylphosphatidylinositol anchor, is an essential coreceptor for Nodal and is required for Nodal signaling. Cripto contains the following two functional domains that play distinct roles in Nodal signaling: a truncated epidermal growth factor-like (EGF) repeat and the CFC domain (2). Cripto and Nodal null mouse embryos exhibit extremely similar phenotypes, both lacking embryonic mesoderm and definitive endoderm (2-5). Cripto is also a co-receptor for GDF1/Vg1, another member of the TGF-␤ superfamily (6). In addition, mouse Gdf3 (growth-differentiation factor 3) is similar to Nodal in requiring Cripto for its signaling activity (7). More recently, other factors were found to regulate Nodal signaling via interaction with Cripto, including activin (8), Lefty (9, 10), and Tomoregulin-1(TMEFF1) (11). In addition, Cripto has been shown to activate the Ras/Raf/MAPK pathway (12-18) and the phosphatidylinositol 3-kinase/AKT pathway (19) independently of Nodal signaling. In fact, these signaling events appear to be triggered by the direct interaction of Cripto with Glypican-1. Finally, Cripto has been implicated in the formation of multiple tumors, including breast, pancreatic, and colorectal cancer (reviewed in Ref. 20).
Nodal, a member of the TGF-␤ 4 superfamily, plays essential roles in the embryonic development of vertebrates, including mesoderm formation and the generation of left-right asymmetry (1) . The major components of the Nodal-signaling pathway are the soluble ligand Nodal, activin membrane receptors (ActRIIB and ALK4) to which Nodal binds, Smad2 and Smad4 signal-transducing molecules, and the transcription factor Fast1 (FoxH1). In addition, Cripto, a membrane glycoprotein with a glycosylphosphatidylinositol anchor, is an essential coreceptor for Nodal and is required for Nodal signaling. Cripto contains the following two functional domains that play distinct roles in Nodal signaling: a truncated epidermal growth factor-like (EGF) repeat and the CFC domain (2) . Cripto and Nodal null mouse embryos exhibit extremely similar phenotypes, both lacking embryonic mesoderm and definitive endoderm (2) (3) (4) (5) . Cripto is also a co-receptor for GDF1/Vg1, another member of the TGF-␤ superfamily (6) . In addition, mouse Gdf3 (growth-differentiation factor 3) is similar to Nodal in requiring Cripto for its signaling activity (7) . More recently, other factors were found to regulate Nodal signaling via interaction with Cripto, including activin (8) , Lefty (9, 10) , and Tomoregulin-1(TMEFF1) (11) . In addition, Cripto has been shown to activate the Ras/Raf/MAPK pathway (12) (13) (14) (15) (16) (17) (18) and the phosphatidylinositol 3-kinase/AKT pathway (19) independently of Nodal signaling. In fact, these signaling events appear to be triggered by the direct interaction of Cripto with Glypican-1. Finally, Cripto has been implicated in the formation of multiple tumors, including breast, pancreatic, and colorectal cancer (reviewed in Ref. 20) .
O-Fucosylation is a comparatively rare form of glycosylation in which fucose is transferred to Thr or Ser in EGF repeats with the consensus sequence, C 2 -X 4 -5 -(T/S)-C 3 , which occur in a variety of proteins, including urinary-type plasminogen activator (uPA) (21) , clotting factors VII and IX (22) , Notch receptors (23) and their ligands (24) , and Cripto (25, 26) (for an extensive list of predicted targets, see Ref. 27) . To date, O-fucose has been reported to be required for the function of uPA (21) , Cripto (25, 26) , and Notch receptors (28 -33) . uPA lacking O-fucose loses its mitogenic but not its receptor binding activity, suggesting that O-fucose is required for uPA-induced signaling (21) . In the case of Cripto, Thr to Ala substitution in the EGF repeat of human or mouse Cripto leads to an inactive Cripto unable to facilitate Nodal signaling in cell-based assays (25, 26) . The requirement of O-fucose for Notch receptors to function has been demonstrated in several contexts. Lec13, a CHO mutant cell line, which is defective in GDP-fucose synthesis and thereby has insufficient O-fucosylation on Notch receptors, has impaired Jagged1-induced Notch signaling (28, 29) . In addition, inactivation of Pofut1 (protein O-fucosyltransferase 1), the glycosyltransferase that catalyzes the addition of fucose to EGFcontaining proteins, results in severe Notch signaling defects in both Drosophila and mouse (30, 31, 34) . Finally, mutation of O-fucose glycosylation sites (Thr to Ala mutations) within either EGF repeat 12 or 27 of mouse Notch1 causes a significant reduction in Notch signaling activity in cell-based assays (32) .
O-Fucosylation also occurs in thrombospondin type 1 repeats (TSRs) (35, 36) . Pofut1 cannot add O-fucose to TSRs, suggesting the presence of another enzyme (37) . A distantly related protein O-fucosyltransferase encoded by the Pofut2 gene in the metazoa (38) has been shown recently to catalyze the transfer of fucose to Thr or Ser in TSR with the consensus CXX(S/T))CXXG (37, 39) . The Drosophila form of Pofut2 (OFUT2) is not capable of adding O-fucose to an EGF repeat from human factor VII in vitro (39) . The O-linked fucose on TSRs can be elongated by a ␤1,3-linked glucose (36, 37, 40, 41) .
Because O-fucose appeared to be essential for Cripto/Nodal signaling, we had expected that targeted mutation of Pofut1 would give rise to a Cripto Ϫ/Ϫ phenotype. Cripto null embryos are described as "trunkless" and die at about E7.5 (2-5). However, Pofut1 Ϫ/Ϫ embryos die later at about E9.5 with a phenotype consistent with a global deficiency in the canonical Notch signaling pathway (30 
EXPERIMENTAL PROCEDURES
ES Cell Lines-ES cell lines were isolated from outgrowths of blastocysts obtained from mating Pofut1 ϩ/Ϫ heterozygotes and genotyped as described previously (43) . Independent cell lines with the Pofut1 ϩ/ϩ , Pofut1 ϩ/Ϫ or Pofut1 Ϫ/Ϫ genotype were obtained.
Expression Constructs-The constructs for Nodal signaling assays (all derived from mouse) were kindly provided by Dr. Michael Shen (Rutgers University) (26) . They were pcDNA3-FLAG-Cripto, pcDNA3-HA-Cripto, pcDNA3-FLAG-Cripto (tr1) carrying three point mutations in the EGF-like domain (L75A/S77A/F78A), pcDNA-FLAG-Cripto(T72A), pcDNA3-Nodal, pcDNA-Fast-2, and the A3-luc luciferase reporter, which contains three tandem repeats of a Nodal-responsive element from the Xenopus Mix.2 gene (26) . Renilla luciferase, pRL-TK (Promega), was used for normalization. pcDNA3 (Invitrogen) was used to maintain the same DNA concentration in transfection experiments. The mouse Notch1 fragment containing the N terminus and EGF repeats 1-18 with a Myc-His 6 C-terminal tag was described previously (46) .
Preparation of Cell Extracts-Pofut1 ϩ/ϩ and Pofut1 Ϫ/Ϫ ES cells grown in the absence of feeder cells were genotyped with the primers PS644 and PS645 as described previously (43) . Cells were grown on 10-cm gelatin-coated dishes with ES cell culture medium. When the cells became confluent, they were scraped off the plate and washed three times with TBS (10 mM Tris-HCl, pH 7.5, 0.15 M NaCl). The cell pellet was placed on ice, and 2 ml of lysis buffer (TBS with 1% Nonidet P-40) and 1ϫ protease inhibitor mixture (Roche Applied Science) was added. The cells were resuspended by pipetting and incubated on ice for 15 min with repeated vortexing. The cell lysate was spun at ϳ12,000 ϫ g for 10 min at 4°C. The supernatant was snap-frozen using liquid nitrogen and stored at Ϫ80°C.
Protein O-Fucosyltransferase 1 Assays-Assays for Pofut1 activity were performed essentially as described previously (39, 47) . Substrates for the assays were produced as follows. 1) ES cells cultured in a 10-cm gelatinized plate to 50% confluency were transfected with 24 g of Notch1 EGF1-18 DNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction. After 24 h, the medium was collected and centrifuged, and the supernatant was incubated on a rotator with 50 l of Ni 2ϩ -nitrilotriacetic acid-agarose (Qiagen) for 1 h at 4°C. The agarose beads were washed five times in 50 mM TrisHCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, and complete protease inhibitor (Roche Applied Science) mixture. 2) Production of bacterially expressed EGF repeat 1 from human factor VII was described previously (39, 48, 49) . 3) To produce the EGF repeat (amino acids 62-91) from mouse Cripto, the corresponding DNA sequences were amplified from pcDNA3-HA-Cripto and subcloned into the BamHI and XhoI sites of the pET20bϩ plasmid, in-frame with the C-terminal His 6 tag. The primers used were 5Ј-ACCGAAGGATCCTAAGTCGCTTAATAAAAC-TTGC-3Ј and 5Ј-TGAAATCTCGAGGCGAACATCATGT-TCACAGTTGCG-3Ј. The EGF repeat was expressed in bacteria and purified as described (49) . Bacterial expression and characterization of the third thrombospondin type 1 repeat from human thrombospondin-1 (TSR3-TSP1) were performed as described (37) . All acceptors were assayed for their ability to be a substrate for the transfer of fucose from GDP-[ 3 H]fucose by Pofut1 and Pofut2 present in extracts of ES cells as described (39, 47) . Products of the assay were separated and counted or analyzed by SDS-PAGE.
Site-directed Mutagenesis of Cripto and Notch1-pcDNA3-FLAG-Cripto was used as a template in the QuikChange site-directed mutagenesis kit (Stratagene) according to manufacturer's instructions. All mutants except those provided by Michael Shen (Rutgers University) were generated in the Stony Brook University Molecular Cloning Service Core. All constructs were sequenced to confirm mutagenesis. A full-length construct of mouse Notch1, in which the C-terminal PEST domain is replaced by six tandem MYC epitopes in pCS2ϩ, was a kind gift of Raphael Kopan (Washington University School of Medicine). The primers to generate N1/T12S and N1/EGF11-15/T12S were 5Ј-CCATGTCAGAATGATGC-CTCGTGCCTGGACCAGATTG-3Ј and 5Ј-CAATCTGGTC-CAGGCACGAGGCATCATTCTGACATGG-3Ј; the primers to generate N1/T12A were 5Ј-CCATGTCAGAATGACGC-CGCATGCCTGGACCAGATTG-3Ј and 5Ј-CAATCTGGTC-CAGGCACGTGGCGTCATTCTGACATGG-3Ј; the primers to generate the N1/T12A revertant were 5Ј-CCATGTCAGA-ATGATGCCACTTGCCTGGACCAGATTG-3Ј and 5Ј-CAA-TCTGGTCCAGGCAAGTGGCATCATTCTGACATGG-3Ј; and the primers for N1/EGF11-15 and EGF11-15T12A were described previously (46) . The QuikChange site-directed mutagenesis protocol from Stratagene was used for site-directed mutagenesis. All constructs were sequenced to confirm nucleotide changes.
Analysis of O-Fucosylation-O-Fucosylation of wild type and mutant forms of mouse Cripto was evaluated as described (26), and O-fucosylation of Notch fragments N1/EGF11-15 (with C-terminal Myc-His 6 tags) and mutants T466A and T466S was determined essentially as described (46) . In brief, expression constructs were transiently expressed in Pro Ϫ Lec1.3C Chinese hamster ovary (Lec1 CHO) cells (50) using FuGENE 6 (Roche Applied Science) or GenePorter (Genlantis). After 24 h the medium was replaced with fresh medium containing 20 Ci/ml [6- 3 H]fucose (American Radiochemical Corp., St. Louis). After 48 h, medium and lysates were collected, and Notch1 fragments were purified by rotating with Ni 2ϩ -nitrilotriacetic acid-agarose beads (Qiagen) overnight at 4°C. After washing five times with 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% SDS, fragments were eluted with 100 mM EDTA, pH 8.0. After electrophoresis on a 10% SDS gel, the dried gel was treated with EN 3 HANCER (PerkinElmer Life Sciences) and exposed for 1 week at Ϫ80°C to a BioMax MS film (Eastman Kodak Co.).
Nodal Signaling Assay with ES Cells and 293T Cells-A method to assay Nodal signaling was developed in ES cells based on Yan et al. (26). Briefly, ES cells (5 ϫ 10
5 ) were plated in 24-well plates. Transfection was performed after 24 h (ϳ50% confluency) with 50 ng of Renilla luciferase DNA, 300 ng of A3-luc reporter, 300 ng of pcDNA3-Fast, 400 ng of pcDNA3-HA-Cripto, 400 ng of pcDNA3-Nodal, and various amounts of pcDNA3 to bring the DNA concentration to 1.45 g. The DNA was mixed with 4 l of Lipofectamine-2000 (Invitrogen) and added to each well with 1 ml of Opti-MEM medium (Invitrogen) containing an additional 3% fetal bovine serum (FBS; Gemini). After 24 h at 37°C, the cells were lysed by overlaying 300 l of lysis buffer from the Dual-Luciferase Reporter Assay System (E1910, Promega), and rocked at room temperature for 15 min. The cell lysate was transferred to an Eppendorf tube and frozen at Ϫ80°C. After thawing and vortexing, luciferase activity assays were conducted according to the manufacturer's instruction using a luminometer. Renilla luciferase activity was used to normalize for differences in transfection efficiency. Each signaling assay was performed in duplicate and was repeated at least twice. The Nodal signaling assay in HEK-293T cells was the same except that the cell density at transfection was ϳ80%.
Differentiation of Embryoid Bodies into Cardiomyocytes-Independently derived Pofut1
Ϫ/Ϫ and Pofut1 ϩ/ϩ ES cell lines were differentiated into embryoid bodies (EB) as described with minor modification (51) . Briefly, undifferentiated ES cells passaged twice to remove feeder cells were cultured in hanging drops of 500 cells at 37°C in 5% CO 2. After 2 days the cells were cultured in suspension until EBs formed, and then replated onto gelatin-coated tissue culture plates. Differentiation medium was high glucose Dulbecco's modified Eagle's medium (Invitrogen) containing 20% heated-inactivated FBS (Gemini), 25 mM HEPES, 0.1 mM mercaptoethanol, nonessential amino acids, and 2 mM glutamine (Specialty Media), but lacking LIF. Rythmic beating of EBs was monitored daily by phase microscopy, and the numbers of beating EBs were counted on day 10.
Reverse Transcriptase-PCR (RT-PCR)-Total RNA from either undifferentiated ES cells or EBs was extracted with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. 1 g of total RNA was reverse-transcribed to cDNA with Takara RNA PCR kit version 2.1 (Takara) using oligo(dT) in 20 l, and 1 l of the reverse transcription product was used for PCR. PCR was performed using the following primers and PCR conditions (51): for cardiac ␣-myosin heavy chain, 5Ј-GGAAGAGTGAGCGGCGCATCAAGG (reverse) and 5Ј-CTGCTGGAGAGGTTATTCCTGG (forward), 64°C annealing temperature, 301-bp product; for myosin light chain isoform 2V (MLC-2V), 5Ј-TGTGGGTCACCTGAGGCTGTG-GTTCAG (forward) and 5Ј-GAAGGCTGACTATGTCCGG-GAGATGC (reverse), 60°C annealing temperature, 189-bp product; for Nkx2.5, 5Ј-CGACGGAAGCCACGCGTGCT (forward) and 5Ј-CCGCTGTCGCTTGCACTTG (reverse), 60°C annealing temperature, 181-bp product; for ␤-tubulin control, 5Ј-GGAACATAGCCGTAAACTGC (forward) and 5Ј-TCACTGTGCCTGAACTTACC (reverse), 60°C annealing temperature, 317-bp product.
Notch Signaling Assay-CHO cells (Pro Ϫ 5; 1.5 ϫ 10 5 ) were plated in a 6-well plate, and the next day were transiently transfected with 150 ng of wild type or mutant pCS2ϩNotch1, 200 ng of TP-1 luciferase Notch reporter construct, and 8 ng of CMV-Renilla luciferase reporter to normalize transfection efficiency using FuGENE 6 (Roche Applied Science) according to the manufacturer's specifications. After incubation for 16 h in a 37°C incubator, FuGENE 6 reagent was removed, and fresh ␣-minimum Eagle's medium containing 10% FBS (Gemini) was added. L cells (1.5 ϫ 10 6 ) or L cells selected by flow cytometry to express high levels of Delta1 (43) were added to duplicate wells. After 30 h of co-culture, cell lysates were prepared in the lysis buffer provided in the Promega dual luciferase kit. Fold activation after normalization was determined as described (28) . To compare the effects of introduced wild type and mutant Notch1, Notch signaling because of endogenous Notch signaling that occurred in vector control cultures was subtracted.
Pofut1
ϩ/ϩ mice. To determine that Pofut1 Ϫ/Ϫ cells lack Pofut1 activity, a mouse Notch1 N-terminal fragment containing EGF repeats 1-18 was transiently expressed in both Pofut1 Ϫ/Ϫ and Pofut1 ϩ/ϩ ES cells, purified from media on nickel-nitrilotriacetic acid-agarose, and incubated with recombinant Pofut1 and GDP-[ 3 H]fucose in vitro. After 12 h at 37°C, the beads were washed extensively, boiled in SDS-PAGE loading buffer, and analyzed by Western blot analysis and fluorography. Significantly less EGF1-18 protein was recovered from Pofut1 Ϫ/Ϫ compared with Pofut1 ϩ/ϩ cells, suggesting that the loss of Pofut1 affects secretion of this Notch1 fragment (Fig. 1A) . The fluorograph of the same samples shows that Notch1 EGF1-18 from Pofut1 Ϫ/Ϫ cells was a substrate for fucosylation with Pofut1 in vitro, indicating that O-fucose sites are unoccupied on this protein. In contrast, Notch1 EGF1-18 from Pofut1 ϩ/ϩ cells was not a substrate for in vitro fucosylation, even though it was present in excess, consistent with all O-fucose sites being already occupied. Therefore, loss of Pofut1 in ES cells significantly reduces or eliminates O-fucosylation of Notch1.
As an alternative approach to analyzing the activity of Pofut1, cell extracts were prepared from Pofut1 ϩ/ϩ (8-8) and Pofut1 Ϫ/Ϫ (5-6-1) ES cells, and incubated with GDP-[ 3 H]fucose and a bacterially expressed (i.e. nonfucosylated) EGF repeat from human factor VII. As expected, extracts from Pofut1 ϩ/ϩ cells were able to fucosylate the factor VII EGF repeat, whereas those from the Pofut1 Ϫ/Ϫ cells were not (Fig. 1B) . The presence of Pofut2 in ES cell extracts was examined by incubating with a bacterially expressed (i.e. nonfucosylated) thrombospondin type 1 repeat from human thrombospondin-1 (TSR3-TSP1). TSR3-TSP1 can be modified by Pofut2, but not by Pofut1, in in vitro assays (37, 39 (Fig. 1B) (52) . Nodal signaling by Pofut1 ϩ/ϩ (8-8) compared with Pofut1 Ϫ/Ϫ (5-6-3) ES cells was assayed in three ways. First, a Nodal cDNA was transfected alone as a measure of endogenous Cripto activity; second, a Cripto cDNA was transfected alone as a measure of endogenous Nodal activity; and third, Nodal and Cripto cDNAs were transfected together. In all cases a Fast2-firefly luciferase reporter construct (A3-luc) and Renilla luciferase construct were co-transfected. The three different assays gave similar signaling results in both Pofut1 ϩ/ϩ and Pofut1 Ϫ/Ϫ (5-6-3) ES cells ( Fig. 2A) , suggesting that O-fucose on Cripto is not required for Nodal signaling. The results show that exogenous Nodal increased signaling by ϳ25% in both Pofut1 ϩ/ϩ and Pofut1 Ϫ/Ϫ ES cells (Fig. 2B) , indicating that endogenous Cripto does not need O-fucose to facilitate Nodal signaling. Exogenous Cripto reproducibly resulted in an ϳ80% increase in signaling in both wild type and mutant cells (Fig. 2C) , demonstrating that there is no significant difference in Nodal signaling between ES cells that add O-fucose to Cripto and those that do not.
O-Fucose Is Not Required for Cripto to Function in EB Differentiation into Cardiomyocytes-Cripto/Nodal signaling is required for cardiomyogenesis because ES cells lacking Cripto fail to form cardiomyocytes from EB (44, 45). Thus, if O-fucose is necessary for Cripto function, Pofut1
Ϫ/Ϫ ES cells should have lost their potential to become cardiomyocytes. We compared the capacity of Pofut1 ϩ/ϩ and Pofut1 Ϫ/Ϫ ES cells in cardiomyogenesis by using several independent ES lines, 
, and 5-6-1 (Pofut1 Ϫ/Ϫ ). Each ES line had essentially the same potential to differentiate into cardiomyocytes as shown by the efficiency of formation of beating EBs (Fig. 3A) . Under our experimental conditions, ϳ50% of the EBs derived from Pofut1
ϩ/Ϫ , and Pofut1 Ϫ/Ϫ ES cell lines were beating after 10 days of culture. To confirm that cardiomyocytes had been formed, RT-PCR for the expression of marker genes up-regulated in cardiomyogenesis was performed (Fig.  3B) . It can be seen that whereas all ES cell lines do not express the myosin heavy chain, myosin light chain, or the transcription factor Nkx2.5, each of these genes is expressed by all EBs at day 10 of culture when EBs are beating. These data demonstrate that Cripto without O-fucose in three independent Pofut1 with Ala abrogates Cripto function (25, 26) . Therefore, we investigated an alternative possibility that the Thr at position 72 and not the attached O-fucose is essential for Cripto to function. To examine this question directly, a T72S mutant of Cripto was generated by site-directed mutagenesis. To determine whether T72S was O-fucosylated, wild type, T72A, and T72S Cripto expression constructs in the pcDNA3-FLAG vector were transfected into 293T cells and cultured in medium containing [ 3 H]fucose. After immunoprecipitation with anti-FLAG antibody, N-glycanase digestion was used to remove [ 3 H]fucose incorporated into complex N-glycans, and the sample was subjected to SDS-PAGE followed by Western analysis with anti-FLAG antibody or fluorography (Fig. 4) . After N-glycanase digestion, wild type and T72S Cripto remained radiolabeled, indicating that both were O-fucosylated (Fig. 4) . Comparison of protein expression levels detected by Western analysis suggests that the extent of O-fucosylation in wild type and T72S Cripto was similar. In contrast, Cripto T72A was no longer modified with [ 3 H]fucose, consistent with the absence of O-fucose.
Cripto with a T72S Mutation Is O-Fucosylated but Poorly
To determine whether O-fucosylated Cripto T72S retains activity, a Nodal signaling assay was performed in 293T cells expressing Cripto T72S and Cripto T72A. Although the expression level of both Cripto mutants was similar to wild type (Fig.  5A) , Nodal signaling activity with Cripto T72S was reduced to a level similar to that of Cripto T72A (Fig. 5B) were well expressed as determined by Western analysis (Fig.  5A) . Notably, none were as defective in signaling as a triple Cripto mutant (tr1) that carries three point mutations in the EGF repeat (L75A/S77A/F78A) (26) . Point mutants almost as defective as Cripto(tr1) were Cripto with Asp, Glu, or Asn at position 72. The remaining Cripto mutants (Ala, His, Lys, Gln, Ser, Val, and Tyr at position 72) showed slightly more signaling activity. Similar results were obtained in Nodal signaling assays using a subset of these Cripto mutants expressed in Pofut1 (32, 53) , although in some species (e.g. Drosophila), the fucose is attached to Ser and in others (e.g. mouse, human) to Thr. In Drosophila, a Ser to Val mutation at the O-fucosylation site of EGF12 of Notch results in Notch activation by Serrate even in the presence of Fringe, in the context of a developing wing disc (53) . A Thr to Ala mutation (T466A) in EGF12 of mouse Notch1 has a profoundly inhibitory effect on Notch1 signaling induced by either Jagged1 or Delta-like1 in a co-culture reporter assay (32) . To determine whether the presence of O-fucose or Thr 466 is required in EGF12 of Notch1 for Notch signaling, Notch1 T466A and T466S mutants were compared for Notch1 signaling. [ 3 H]Fucose was not incorporated into a mouse Notch1 EGF11-15 fragment with the T466A mutation (Fig. 6A) as shown previously (46) . In contrast, [ 3 H]fucose was incorporated into Notch1/T466S equivalently to Notch1T466 (Fig. 6A) . Delta1-induced Notch signaling was greatly inhibited by the T466A mutation in a Notch signaling assay (Fig. 6B) . As expected, signaling was recovered in the Notch1/A466T revertant. Importantly, when Ala at 466 was replaced with Ser that can accept O-fucose, Notch1 signaling was also recovered (Fig.  6B) . Therefore, Notch1 signaling in this reporter assay requires O-fucose at amino acid 466 in EGF12, and the O-fucose can be attached to either Thr or Ser. Therefore, the lack of a functional requirement for O-fucose in the EGF repeat of Cripto may be specific to Cripto.
DISCUSSION

O-Fucose Is Not Required for Cripto to Facilitate Nodal
Signaling-Previously we showed that E6.5 embryos lacking Pofut1 do not exhibit Cripto null phenotypes (30) . Rather, these embryos have defects typical of a global loss of Notch signaling through all four Notch receptors. In this study, we provide an explanation for these observations. Using several different experimental strategies, we show that O-fucose is dispensable for active Cripto in Nodal signaling. In summary we found the following. 1) Cripto is a substrate of Pofut1 and not Pofut2. Asp, Glu, His, Lys, Asn, Gln, Val, or Tyr at position 72 has significantly impaired Cripto activity, indicating that Thr 72 may be uniquely required for Cripto to facilitate Nodal signaling. The fact that Cripto T72S has similar activity to Cripto T72A suggests that the methyl group of Thr 72 plays a critical role in the ability of Cripto to support Nodal signaling. This role is likely to be direct because Cripto T72A is stable at the cell surface and appears to be folded appropriately in that its binding to ActR1B at the cell surface is normal (54) . Further evidence of appropriate folding is that both T72A and T72S Cripto are N-glycosylated at Asn 63 (data not shown), which is close to Thr 72 in a three-dimensional model (54) . In fact, the O-fucosylation of T72S also indicates appropriate folding because Pofut1 will only transfer fucose to a folded EGF repeat (55) .
Cripto T72A and Other Mutants Still Retain Some ActivityAlthough all of the Thr 72 Cripto mutants had reduced activity in signaling assays, several retained the ability to support low levels of Nodal signaling (Fig. 6B ). This observation is in agreement with previous results. The human T88A Cripto mutant exhibits a low level of activity in a Nodal signaling assay with F9 teratocarcinoma cells (25) . In addition, purified T72A Cripto was able to restore the capacity of Cripto null ES cells to form beating EB, although a much higher concentration was needed compared with purified wild type Cripto (45) . As a control, a mouse Cripto mutant bearing three point mutations (L75A/S77A/F78A) in the EGF repeat (26) were tested, and it exhibited the lowest activity compared with other mutants in cell-based signaling assays (Fig. 6B) . In the ES cell-based signaling assays this mutant exhibited complete loss of activity (data not shown).
Thr 72 Is Located in a Region That May Directly Interact with Nodal-Several residues that are crucial for the activity of mouse Cripto were identified previously based on their inability to rescue the Zebrafish MZoep mutant phenotype (54) . These residues are exposed and on the same side of a three-dimensional model of Cripto. One of the mutations that is immediately adjacent to Thr 72 , G71N, resulted in a complete loss of activity of Cripto. Another critical residue is Phe 78 , mutation of which to Ala inactivates Cripto completely. This is also spatially close to Gly 71 and Thr 72 . These residues form a surface in the three-dimensional model, and it may function as an interface that directly interacts with or binds to Nodal because Cripto binds to Nodal via its EGF repeat (15, 26, 56) . The fact that the T72A mutation eliminates the binding of Cripto to Nodal (26) supports this hypothesis. In addition, Thr in the EGF domain is absolutely conserved across all EGF-CFC family members (26 (6, 9) , and Tomoregulin also blocks Nodal signaling via direct binding to the CFC domain of Cripto (11) . O-Fucose may not be involved in the interaction of Cripto with these molecules because Pofut1 Ϫ/Ϫ embryos were normal through the stage at which these molecules block Nodal to ensure embryonic development (58) .
Cripto has been shown to activate both Ras/Raf/MAPK and phosphatidylinositol 3-kinase/AKT pathways independently of Nodal signaling (59, 60) via direct interaction with Glypican-1 (61) . The interacting region of Cripto with Glypican-1 most likely localizes to the EGF repeat because a refolded peptide containing only the EGF repeat of Cripto is able to activate the two pathways (59) . It would be interesting to know if this interaction requires the O-fucose and/or Thr 72 . The protein that was first reported to require O-fucose for activity was uPA (21) . The removal of O-fucose from Thr 18 in the EGF (GFD) domain of uPA by treatment of trifluoroacetic acid led to the loss of its mitogenic activity. In addition, uPA purified from Escherichia coli also fails to elicit a mitogenic response in cells although it binds to the receptor with equal affinity to wild type uPA. The authors speculated that O-fucosylation might serve as a trigger to elicit a mitogenic response. To further test this hypothesis, it would be helpful to prepare uPA from Pofut1 Ϫ/Ϫ ES cells and test it for mitogenic activity. O-Fucose Is Required for Notch1 Signaling in a Co-culture Assay-O-Fucose on Notch EGF12 is highly conserved in the ligand-binding domain of many species (33, 62) . In Drosophila, a Ser to Val mutation at the O-fucosylation site of Notch EGF12 results in Notch activation even in the presence of Fringe, suggesting that O-fucose at this site is inhibitory in the developing wing disk (53) . The absence of the O-fucose at this site facilitates ligand binding (53) . In vitro binding of a bacterially expressed (and therefore unfucosylated) fragment of mouse Notch1 (EGF repeats 11-13) fragment to Delta1 also suggests that the O-fucose on EGF repeat 12 is not essential for ligand binding, although functional binding was not examined (63) . Interestingly, a Thr to Ala mutation within the O-fucosylation site of mouse Notch1 had a profound effect on Notch activation by either Jagged1 or Delta-like 1 in cell-based assays (32) . The differences in these results are most likely because of differences in the systems being studied. We show in Fig. 6 that O-fucose is required in EGF12 for mouse Notch1 to signal in a coculture assay. Thus, Ser can replace Thr at amino acid 466 and give an active Notch1, but Ala, which cannot be modified by O-fucose, causes Notch1 to become inactive in this assay.
Split, a mutation of Ile 578 -Thr in EGF repeat 14 of Drosophila Notch, creates a new O-fucosylation site. The consequence of this mutation is the activation of Notch receptor in R8 cells to respond to Delta ligand in adjacent cells. Wild type Notch receptor in R8 cells is not able to respond to Delta on adjacent cells. This activation of Notch is considered to be associated with the O-fucose (42) . However, based on our results, it is possible that the methyl group of the Thr may contribute to the phenotypes observed.
Advantages of Pofut1 Ϫ/Ϫ ES Cells in the Functional Studies of O-Fucosylation-The Pofut1
Ϫ/Ϫ ES cells used here in Nodal signaling and elsewhere in Notch signaling assays (43) can be used for the production of O-fucose-free proteins that normally carry fucose on their EGF repeats, allowing the role of O-fucose on these proteins to be evaluated. These cells are particularly advantageous when compared with other approaches to eliminate O-fucose from proteins, such as chemical treatments, sitedirected mutagenesis, and bacterial expression, because these methods could potentially give rise to artifacts.
